中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
24期
80-82
,共3页
张翠英%栗志平%李菊平%杨妮娜%赵芳
張翠英%慄誌平%李菊平%楊妮娜%趙芳
장취영%률지평%리국평%양니나%조방
大肠埃希菌%抗菌药物%耐药趋势
大腸埃希菌%抗菌藥物%耐藥趨勢
대장애희균%항균약물%내약추세
Escherichia coli%Antimicrobial agents%Drug-resistant trend
目的 研究长治市第二人医院2008年至2012年大肠埃希菌的临床分布特点及对常用抗菌药物的耐药趋势变化,为临床预防和控制大肠埃希菌感染提供依据.方法 对5年间从临床各种标本中分离的大肠埃希菌进行回顾性分析,菌株鉴定采用API及ATB鉴定仪,采用CLSI推荐的K-B法进行药敏试验和折点判读.ESBLs确证试验采用双纸片法.结果 共分离大肠埃希菌804株,其中产ESBLs 344株,占42.79%.804株大肠埃希菌中来自尿液标本426株,占52.99%;疫标本135株,占16.79%;脓和分泌物132株,占16.42%;血液标本39株,占4.85%.大肠埃希菌对左氧氟沙星、头孢唑啉、头孢呋辛、庆大霉素、妥布霉素的耐药率较高(>50%),且对左氧氟沙星的耐药率呈逐年上升趋势;对头孢哌酮/舒巴坦、哌拉西林/他唑巴坦、阿米卡星、呋喃妥因的耐药率较低(<10%);对亚胺培南的耐药率为0.结论 大肠埃希菌的检出率及其对多种抗生素的耐药率维持在较高水平,应根据药敏结果,合理应用抗菌药物,预防耐药菌的产生.
目的 研究長治市第二人醫院2008年至2012年大腸埃希菌的臨床分佈特點及對常用抗菌藥物的耐藥趨勢變化,為臨床預防和控製大腸埃希菌感染提供依據.方法 對5年間從臨床各種標本中分離的大腸埃希菌進行迴顧性分析,菌株鑒定採用API及ATB鑒定儀,採用CLSI推薦的K-B法進行藥敏試驗和摺點判讀.ESBLs確證試驗採用雙紙片法.結果 共分離大腸埃希菌804株,其中產ESBLs 344株,佔42.79%.804株大腸埃希菌中來自尿液標本426株,佔52.99%;疫標本135株,佔16.79%;膿和分泌物132株,佔16.42%;血液標本39株,佔4.85%.大腸埃希菌對左氧氟沙星、頭孢唑啉、頭孢呋辛、慶大黴素、妥佈黴素的耐藥率較高(>50%),且對左氧氟沙星的耐藥率呈逐年上升趨勢;對頭孢哌酮/舒巴坦、哌拉西林/他唑巴坦、阿米卡星、呋喃妥因的耐藥率較低(<10%);對亞胺培南的耐藥率為0.結論 大腸埃希菌的檢齣率及其對多種抗生素的耐藥率維持在較高水平,應根據藥敏結果,閤理應用抗菌藥物,預防耐藥菌的產生.
목적 연구장치시제이인의원2008년지2012년대장애희균적림상분포특점급대상용항균약물적내약추세변화,위림상예방화공제대장애희균감염제공의거.방법 대5년간종림상각충표본중분리적대장애희균진행회고성분석,균주감정채용API급ATB감정의,채용CLSI추천적K-B법진행약민시험화절점판독.ESBLs학증시험채용쌍지편법.결과 공분리대장애희균804주,기중산ESBLs 344주,점42.79%.804주대장애희균중래자뇨액표본426주,점52.99%;역표본135주,점16.79%;농화분비물132주,점16.42%;혈액표본39주,점4.85%.대장애희균대좌양불사성、두포서람、두포부신、경대매소、타포매소적내약솔교고(>50%),차대좌양불사성적내약솔정축년상승추세;대두포고동/서파탄、고랍서림/타서파탄、아미잡성、부남타인적내약솔교저(<10%);대아알배남적내약솔위0.결론 대장애희균적검출솔급기대다충항생소적내약솔유지재교고수평,응근거약민결과,합리응용항균약물,예방내약균적산생.
Objective To study E.coli clinical distribution characteristics and drug resistance to commonly used antimicrobial agents trend change in the second people' s hospital of Changzhi from 2008 to 2012,in order to provide the basis for clinical prevention and control of E.coli infection.Methods All kinds of E.coli isolated from clinical specimens in five years were retrospectively analyzed.API and ATB bacteria identification instrument were used for bacterial strains identification.K-B method recommended by CLSI was used for drug sensitive test and fold point interpretation.ESBLs was confirmed with double slip of paper method.Results A total of 804 strains of E.coli had been separated.There were 344 ESBLs-producing strains,accounting for 42.79%.Among the 804 strains of E.coli,426 strains were isolated from urine,accounting for 52.99% ; 135 strains from sputum,accounting for 16.79% ; 132 strains from pus or secretion,accounting for 16.42% ; and 39 strains from blood,accounting for 4.85%.E.coli demonstrated much higher resistant rate to levofloxacin,cefazolin,cefuroxime,gentamicin,tobramycin(> 50%),the resistant rate to levofloxacin had rising trend year by year,and E.coli had much lower resistant rate to cefoperazone/sulbactam,piperacillin/tazobactam,amikacin,nitrofurantoin.No strains were found to be resistant to imipenem.Conclusions Escherichia coli detection rate and the multiple antibiotic resistant rate of E.coli is maintained at a high level,it should be based on susceptibility results,rational use of antimicrobial drugs to prevent the generation of resistant bacteria.